Skip to content
← The Index board

Promising · 6.4/10

Vilon (Lys-Glu)

Evidence C · mixed evidence ▲ 14.6% momentum 🥇 First scout open
6.4/ 10

Vilon is the Lysine-Glutamic acid (KE) dipeptide from Vladimir Khavinson's bioregulator program, sold for immune restoration and anti-aging. The cell and animal data are real but come entirely from one lab, with zero independent replication and zero registered trials, per the single-source record summarized in Khavinson 2013. It looks harmless, but it is the weakest-evidenced of the Khavinson short peptides. Read the full breakdown →

The prediction game

Where does Vilon (Lys-Glu) go in 12 months?

Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.

The Crowd’s Call

Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.

Your 12-month call on Vilon (Lys-Glu)

New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.

Be the first scout on record for Vilon (Lys-Glu). Permanent credit on this page, plus points when your call resolves.

One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →

Weigh In

Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.

Tried it in real life?

Which ring does it deserve?

Same as above — one verification covers all your entries here.

Ring Promising Momentum 14.6% Updated Jul 20, 2026 How the Index ranks →

Verdict by Nick Urban, host of the High Performance Longevity podcast.

For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.